1
|
Rodríguez-Hernández A, Navarro-Villarán E, González R, Pereira S, Soriano-De Castro LB, Sarrias-Giménez A, Barrera-Pulido L, Álamo-Martínez JM, Serrablo-Requejo A, Blanco-Fernández G, Nogales-Muñoz A, Gila-Bohórquez A, Pacheco D, Torres-Nieto MA, Serrano-Díaz-Canedo J, Suárez-Artacho G, Bernal-Bellido C, Marín-Gómez LM, Barcena JA, Gómez-Bravo MA, Padilla CA, Padillo FJ, Muntané J. Corrigendum to 'Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells'[Redox Biol 6(2015):174-182]. Redox Biol 2023:102744. [PMID: 37246098 DOI: 10.1016/j.redox.2023.102744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Affiliation(s)
- A Rodríguez-Hernández
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013, Sevilla, Spain
| | - E Navarro-Villarán
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013, Sevilla, Spain
| | - R González
- Department of Biochemistry and Molecular Biology, University of Cordoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14071, Córdoba, Spain
| | - S Pereira
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013, Sevilla, Spain
| | - L B Soriano-De Castro
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013, Sevilla, Spain
| | - A Sarrias-Giménez
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013, Sevilla, Spain
| | - L Barrera-Pulido
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - J M Álamo-Martínez
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain; CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
| | - A Serrablo-Requejo
- Hepato-Biliary Surgery Unit, Hospital Universitario "Miguel Servet", Zaragoza, Spain
| | - G Blanco-Fernández
- Hepato-Biliary-Pancreatic and Liver Transplant Service, Hospital Universitario "Infanta Cristina", Badajoz, Spain
| | - A Nogales-Muñoz
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - A Gila-Bohórquez
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - D Pacheco
- Department of General Surgery and Department of Pathology, Hospital Universitario "Rio Hortega", Valladolid, Spain
| | - M A Torres-Nieto
- Department of Pathology, Hospital Universitario "Rio Hortega", Valladolid, Spain
| | - J Serrano-Díaz-Canedo
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - G Suárez-Artacho
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - C Bernal-Bellido
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - L M Marín-Gómez
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - J A Barcena
- Department of Biochemistry and Molecular Biology, University of Cordoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14071, Córdoba, Spain
| | - M A Gómez-Bravo
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain; CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
| | - C A Padilla
- Department of Biochemistry and Molecular Biology, University of Cordoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14071, Córdoba, Spain
| | - F J Padillo
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain; CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
| | - J Muntané
- Department of General Surgery, Hospital Universitario "Virgen del Rocío"-"Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain; CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
| |
Collapse
|
2
|
Fatela-Cantillo D, Gómez-Bravo MÁ, Noval-Padillo JÁ, Álamo-Martínez JM, Bernal-Bellido C, Marín-Gómez LM. Impact of Point-of-Care Assays for Hemostasis Monitoring According to Type of Donor in a Cohort of Liver Transplant Recipients. Transplant Proc 2022. [DOI: 10.1016/j.transproceed.2022.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
3
|
García-Muñoz P, Bernal-Bellido C, Marchal-Santiago A, Cepeda-Franco C, Álamo-Martínez JM, Marín-Gómez LM, Suárez-Artacho G, Castillo-Tuñón JM, Navarro-Morales L, Padillo-Ruíz FJ, Gómez-Bravo MA. Liver Cirrhosis From Chronic Hypervitaminosis A Resulting in Liver Transplantation: A Case Report. Transplant Proc 2019; 51:90-91. [PMID: 30655144 DOI: 10.1016/j.transproceed.2018.03.141] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2018] [Accepted: 03/15/2018] [Indexed: 11/17/2022]
Abstract
Herein we report a case of liver dysfunction caused by consumption of vitamin A supplements leading to liver transplantation. The patient was a 48-year-old male with a medical history of congenital ichthyosiform erythroderma in treatment with vitamin A until 12 years of age, at which point he discontinued the supplements because he had developed ascites. Liver cirrhosis was diagnosed as secondary to hypervitaminosis A on the basis of histologic examination of liver biopsy and the absence of other potential causes of chronic liver disease. Despite interruption of administration of vitamin A, the patient continued to deteriorate over the years, with development of portal hypertension signs. His medical conditions were aggravated with the development of hepatic insufficiency manifested by refractory ascites, renal insufficiency, and severe encephalopathy and he underwent orthotopic liver transplantation, followed by disappearance of all signs of portal hypertension. This case highlights the need to take a careful history of consumption of vitamin A when evaluating a patient with liver failure.
Collapse
Affiliation(s)
- P García-Muñoz
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain.
| | - C Bernal-Bellido
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - A Marchal-Santiago
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - C Cepeda-Franco
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - J M Álamo-Martínez
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - L M Marín-Gómez
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - G Suárez-Artacho
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - J M Castillo-Tuñón
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - L Navarro-Morales
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - F J Padillo-Ruíz
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - M A Gómez-Bravo
- Hepatobiliopancreatic Surgery and Liver Transplantation Unit, Department of General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| |
Collapse
|
4
|
Cepeda-Franco C, Marín-Gómez LM, Bernal-Bellido C, Suárez-Artacho G, Álamo-Martínez JM, Padillo-Ruiz FJ, Gómez-Bravo MÁ. Alternative outflow reconstruction in domino liver transplantation. Liver Transpl 2017; 23:1226-1228. [PMID: 28700814 DOI: 10.1002/lt.24816] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/21/2017] [Revised: 06/14/2017] [Accepted: 06/27/2017] [Indexed: 01/13/2023]
|
5
|
Cepeda-Franco C, Bernal-Bellido C, Barrera-Pulido L, Álamo-Martínez JM, Ruiz-Matas JH, Suárez-Artacho G, Marín-Gómez LM, Tinoco-González J, Díaz-Aunión C, Padillo-Ruiz FJ, Gómez-Bravo MÁ. Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register. Transplant Proc 2017; 48:2983-2986. [PMID: 27932125 DOI: 10.1016/j.transproceed.2016.09.026] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2016] [Revised: 08/16/2016] [Accepted: 09/01/2016] [Indexed: 02/08/2023]
Abstract
Recently, there has been a large discrepancy between the number of patients on the waiting list for a liver transplant and the availability of deceased donors, with an increase in annual wait list mortality rates. Elderly donor livers are thought to be marginal grafts; however, in recent years, their utilization has constantly increased. The aim of this study is to evaluate the utilization of elderly donors in Andalusia and post-transplant outcomes. This retrospective observational study of 2408 liver transplants, performed in Andalusia between 2000 and 2014, analyzes the outcomes from donors aged 70 plus (n = 423) in terms of survival rates of the graft and the recipient, the type of transplant, donor age, and D-MELD score (product of donor age and preoperative Model for End-stage Liver Disease score). The most frequent indications for transplant were alcoholic cirrhosis (49.2%), hepatitis C cirrhosis (13%), and hepatocellular carcinoma (12.5%). The overall survival at 5 years was 64%, with a significant fall in survival for recipients with a D-MELD greater than 1500 (57%; P = .045). In the 70-year-old-plus donor group, the overall patient survival was 58.4%. The retransplant rate increased proportionately with donor age. In the alcoholic cirrhosis recipient subgroup, the overall survival at 5 years was 67.6% (P < .05) compared with 33.5% in patients with hepatitis C. Use of elderly donors is a safe strategy to reduce the scarcity of donors, provided that a D-MELD score below 1500 is obtained. Retransplant rates increase progressively with donor age. It is necessary to carefully screen recipients of older organs, taking into account that the best results are obtained for alcoholic cirrhosis, negative viral load hepatitis C, and a D-MELD score below 1500.
Collapse
Affiliation(s)
- C Cepeda-Franco
- Liver Transplant Unit, Virgen del Rocío University Hospital, Seville, Spain.
| | - C Bernal-Bellido
- Liver Transplant Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - L Barrera-Pulido
- Liver Transplant Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - J M Álamo-Martínez
- Liver Transplant Unit, Virgen del Rocío University Hospital, Seville, Spain
| | | | - G Suárez-Artacho
- Liver Transplant Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - L M Marín-Gómez
- Liver Transplant Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - J Tinoco-González
- Liver Transplant Unit, Virgen del Rocío University Hospital, Seville, Spain
| | | | - F J Padillo-Ruiz
- Liver Transplant Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - M Á Gómez-Bravo
- Liver Transplant Unit, Virgen del Rocío University Hospital, Seville, Spain
| |
Collapse
|
6
|
Tinoco-González J, Suárez-Artacho G, Bernal-Bellido C, Cepeda-Franco C, Ramallo-Solis I, Marín-Gómez L, Álamo-Martínez JM, Serrano-Díez-Canedo J, Padillo-Ruíz J, Gómez-Bravo MA. Analysis of the First 1000 Liver Transplants in Virgen del Rocío Hospital. Transplant Proc 2016; 48:2973-2976. [PMID: 27932122 DOI: 10.1016/j.transproceed.2016.09.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2016] [Revised: 08/29/2016] [Accepted: 09/14/2016] [Indexed: 10/20/2022]
Abstract
The goal of this work has been to analyze the first 1000 liver transplantations (LTs) performed in the Virgen del Rocío Hospital of Seville and to evaluate the changes in that time. We included 916 patients who had 1000 LTs. We distinguish 2 stages in the follow-up: the first stage, between 1990 and 2002, and the second, from 2003 to 2013 (Model for End-stage Liver Disease [MELD] stage). We analyzed recipient features, LT indications, donation criteria, surgical technique, complications, and survival both for patients and grafts. The median age of recipients was 53.50 ± 46.49 years old, with a noticeable increase after 2000. There were 3 times as many men as women. The most frequent indications for LT were hepatocellular disease (48.8%), followed by hepatocarcinoma (17.8%), retransplantation (8.1%), and cholestatic diseases (3.6%). Donors of Andalusian centers accounted for 88.2% of LTs, and 8.3% of LTs presented some arterial or venous complication. Biliary complications occurred in 15.6%. Patient survival at 1, 5, and 10 years was 77%, 63.5%, and 51.3%, respectively. In conclusion, some of the factors that negatively influenced survival of the patient were stage of the LT, hepatitis C virus-positive recipient, emergency cases, hepatocarcinoma, high consumption of blood products, and second transplantations.
Collapse
Affiliation(s)
- J Tinoco-González
- University Hospital Virgen del Rocío, Liver Transplant Unit, Seville, Spain.
| | - G Suárez-Artacho
- University Hospital Virgen del Rocío, Liver Transplant Unit, Seville, Spain
| | - C Bernal-Bellido
- University Hospital Virgen del Rocío, Liver Transplant Unit, Seville, Spain
| | - C Cepeda-Franco
- University Hospital Virgen del Rocío, Liver Transplant Unit, Seville, Spain
| | - I Ramallo-Solis
- University Hospital Virgen del Rocío, Liver Transplant Unit, Seville, Spain
| | - L Marín-Gómez
- University Hospital Virgen del Rocío, Liver Transplant Unit, Seville, Spain
| | - J M Álamo-Martínez
- University Hospital Virgen del Rocío, Liver Transplant Unit, Seville, Spain
| | | | - J Padillo-Ruíz
- University Hospital Virgen del Rocío, Liver Transplant Unit, Seville, Spain
| | - M A Gómez-Bravo
- University Hospital Virgen del Rocío, Liver Transplant Unit, Seville, Spain
| |
Collapse
|
7
|
Segura-Sampedro JJ, Bernal-Bellido C, Marín-Gómez LM, Suárez-Artacho G, Serrano-Díez-Canedo J, Álamo-Martínez JM, Padillo-Ruiz FJ, Gómez-Bravo MÁ. Outcomes of Liver Transplantation During Adulthood After Kasai Portoenterostomy Due to Biliary Atresia. Transplant Proc 2016; 47:2643-4. [PMID: 26680059 DOI: 10.1016/j.transproceed.2015.09.058] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2015] [Revised: 08/12/2015] [Accepted: 09/03/2015] [Indexed: 10/22/2022]
Abstract
Biliary atresia (BA) is a neonatal progressive cholangiopathy of unknown etiology and one of the most common reasons for liver transplantation (LT) in children. Kasai portoenterostomy (KP) improves survival of the native liver, although LT remains the only ultimate treatment. In some cases KP makes it possible to defer the ultimate LT until adulthood. We report our experience regarding 5 cases of BA treated with LT during adulthood. KP was performed in all patients at an average age of 176 days (range, 60-280), which allowed an average survival of the native liver of 19.01 years (range, 14.06-22.32). Five-year survival rate was 100%. Ten-year survival rate did not reach 100% because of a death 9.55 years after LT due to chronic graft rejection, in a patient who was already prepared for a new LT. Our results corroborate that KP remains the first-line treatment of BA. Early performance of the KP provides children with the best chance of survival, allowing the delay of the LT to adulthood. LT during adulthood in these patients achieves good post-LT survival rate; we have not found any data regarding this group of patients in the literature.
Collapse
Affiliation(s)
- J J Segura-Sampedro
- General and Digestive Surgery, Son Espases University Hospital, Palma de Mallorca, Spain; General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain.
| | - C Bernal-Bellido
- General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - L M Marín-Gómez
- General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - G Suárez-Artacho
- General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | | | - J M Álamo-Martínez
- General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - F J Padillo-Ruiz
- General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| | - M Á Gómez-Bravo
- General and Digestive Surgery, Virgen del Rocío University Hospital, Seville, Spain
| |
Collapse
|
8
|
García-Fernández N, Macher HC, Rubio A, Jiménez-Arriscado P, Bernal-Bellido C, Bellido-Díaz ML, Suárez-Artacho G, Guerrero JM, Gómez-Bravo MA, Molinero P. Detection of p53 Mutations in Circulating DNA of Transplanted Hepatocellular Carcinoma Patients as a Biomarker of Tumor Recurrence. Advances in Experimental Medicine and Biology 2016; 924:25-28. [DOI: 10.1007/978-3-319-42044-8_5] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
9
|
Rodríguez-Hernández A, Navarro-Villarán E, González R, Pereira S, Soriano-De Castro LB, Sarrias-Giménez A, Barrera-Pulido L, Álamo-Martínez JM, Serrablo-Requejo A, Blanco-Fernández G, Nogales-Muñoz A, Gila-Bohórquez A, Pacheco D, Torres-Nieto MA, Serrano-Díaz-Canedo J, Suárez-Artacho G, Bernal-Bellido C, Marín-Gómez LM, Barcena JA, Gómez-Bravo MA, Padilla CA, Padillo FJ, Muntané J. Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells. Redox Biol 2015; 6:174-182. [PMID: 26233703 PMCID: PMC4534573 DOI: 10.1016/j.redox.2015.07.010] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2015] [Revised: 07/17/2015] [Accepted: 07/20/2015] [Indexed: 12/15/2022] Open
Abstract
Nitric oxide (NO) plays a relevant role during cell death regulation in tumor cells. The overexpression of nitric oxide synthase type III (NOS-3) induces oxidative and nitrosative stress, p53 and cell death receptor expression and apoptosis in hepatoblastoma cells. S-nitrosylation of cell death receptor modulates apoptosis. Sorafenib is the unique recommended molecular-targeted drug for the treatment of patients with advanced hepatocellular carcinoma. The present study was addressed to elucidate the potential role of NO during Sorafenib-induced cell death in HepG2 cells. We determined the intra- and extracellular NO concentration, cell death receptor expression and their S-nitrosylation modifications, and apoptotic signaling in Sorafenib-treated HepG2 cells. The effect of NO donors on above parameters has also been determined. Sorafenib induced apoptosis in HepG2 cells. However, low concentration of the drug (10nM) increased cell death receptor expression, as well as caspase-8 and -9 activation, but without activation of downstream apoptotic markers. In contrast, Sorafenib (10 µM) reduced upstream apoptotic parameters but increased caspase-3 activation and DNA fragmentation in HepG2 cells. The shift of cell death signaling pathway was associated with a reduction of S-nitrosylation of cell death receptors in Sorafenib-treated cells. The administration of NO donors increased S-nitrosylation of cell death receptors and overall induction of cell death markers in control and Sorafenib-treated cells. In conclusion, Sorafenib induced alteration of cell death receptor S-nitrosylation status which may have a relevant repercussion on cell death signaling in hepatoblastoma cells.
Collapse
Affiliation(s)
- A Rodríguez-Hernández
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013 Sevilla, Spain
| | - E Navarro-Villarán
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013 Sevilla, Spain
| | - R González
- Departament of Biochemistry and Molecular Biology, University of Cordoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14071 Córdoba, Spain
| | - S Pereira
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013 Sevilla, Spain
| | - L B Soriano-De Castro
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013 Sevilla, Spain
| | - A Sarrias-Giménez
- Institute of Biomedicine of Seville (IBiS), Hospital Universitario "Virgen del Rocío"/CSIC/Universidad de Sevilla, Av. Manuel Siurot s/n, 41013 Sevilla, Spain
| | - L Barrera-Pulido
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - J M Álamo-Martínez
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain; CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
| | - A Serrablo-Requejo
- Hepato-Biliary Surgery Unit, Hospital Universitario "Miguel Servet", Zaragoza, Spain
| | - G Blanco-Fernández
- Hepato-Biliary-Pancreatic and Liver Transplant Service, Hospital Universitario "Infanta Cristina", Badajoz, Spain
| | - A Nogales-Muñoz
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - A Gila-Bohórquez
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - D Pacheco
- Department of General Surgery and Department of Pathology, Hospital Universitario "Rio Hortega", Valladolid, Spain
| | - M A Torres-Nieto
- Department of Pathology, Hospital Universitario "Rio Hortega", Valladolid, Spain
| | - J Serrano-Díaz-Canedo
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - G Suárez-Artacho
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - C Bernal-Bellido
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - L M Marín-Gómez
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain
| | - J A Barcena
- Departament of Biochemistry and Molecular Biology, University of Cordoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14071 Córdoba, Spain
| | - M A Gómez-Bravo
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain; CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
| | - C A Padilla
- Departament of Biochemistry and Molecular Biology, University of Cordoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14071 Córdoba, Spain
| | - F J Padillo
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain; CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
| | - J Muntané
- Department of General Surgery, Hospital Universitario "Virgen del Rocío" - "Virgen Macarena"/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Sevilla, Spain; CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
| |
Collapse
|
10
|
Marín-Gómez LM, Álamo-Martínez JM, Suárez-Artacho G, Ramírez-Santos J, Bernal-Bellido C, Barrera-Pulido L, Serrano-Díaz-Canedo J, Padillo-Ruiz FJ, Gómez-Bravo MÁ. Is the sinusoidal obstructive syndrome post-liver transplantation a pathologic entity with a multifactorial etiology? Rev Esp Enferm Dig 2015; 107:235-238. [PMID: 25824926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The sinusoidal obstructive syndrome is a complication typically associated with hematopoietic stem cell transplantation. This syndrome, more commonly known as veno-occlusive disease, has also been described after liver transplantation. It can have a life-threatening course. Herein, we describe the hepatic graft loss secondary to the development of a sinusoidal obstructive syndrome after a severe acute cellular rejection and toxic levels of once daily modified released tacrolimus (TAC). We discuss the role of the endotheliitis of acute rejection and toxic metabolites of some immunosuppressants such as azathioprine and TAC. Based on the current scientific evidence, we contemplate the possibility that the etiology of sinusoidal obstruction syndrome post-liver transplantation is multifactorial.
Collapse
|
11
|
Macher HC, Suárez-Artacho G, Guerrero JM, Gómez-Bravo MA, Álvarez-Gómez S, Bernal-Bellido C, Dominguez-Pascual I, Rubio A. Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor. PLoS One 2014; 9:e113987. [PMID: 25489845 PMCID: PMC4260920 DOI: 10.1371/journal.pone.0113987] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2014] [Accepted: 11/01/2014] [Indexed: 01/14/2023] Open
Abstract
Background Health assessment of the transplanted organ is very important due to the relationship of long-term survival of organ transplant recipients and health organ maintenance. Nowadays, the measurement of cell-free DNA from grafts in the circulation of transplant recipients has been considered a potential biomarker of organ rejection or transplant associated complications in an attempt to replace or reduce liver biopsy. However, methods developed to date are expensive and extremely time-consuming. Our approach was to measure the SRY gene, as a male organ biomarker, in a setting of sex-mismatched female recipients of male donor organs. Methods Cell-free DNA quantization of the SRY gene was performed by real-time quantitative PCR beforehand, at the moment of transplantation during reperfusion (day 0) and during the stay at the intensive care unit. Beta-globin cell-free DNA levels, a general cellular damage marker, were also quantified. Results Beta-globin mean values of patients, who accepted the graft without any complications during the first week after surgery, diminished from day 0 until patient stabilization. This decrease was not so evident in patients who suffered some kind of post-transplantation complications. All patients showed an increase in SRY levels at day 0, which decreased during hospitalization. Different complications that did not compromise donated organs showed increased beta-globin levels but no SRY gene levels. However, when a donated organ was damaged the patients exhibited high levels of both genes. Conclusion Determination of a SRY gene in a female recipient's serum is a clear and specific biomarker of donated organs and may give us important information about graft health in a short period of time by a non-expensive technique. This approach may permit clinicians to maintain a close follow up of the transplanted patient.
Collapse
Affiliation(s)
- Hada C Macher
- Dpt. of Clinical Biochemistry, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain
| | - Gonzalo Suárez-Artacho
- Hepatobiliary and Liver Transplantation Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Juan M Guerrero
- Dpt. of Clinical Biochemistry, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain
| | - Miguel A Gómez-Bravo
- Hepatobiliary and Liver Transplantation Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Sara Álvarez-Gómez
- Dpt. of Clinical Biochemistry, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain
| | - Carmen Bernal-Bellido
- Hepatobiliary and Liver Transplantation Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Inmaculada Dominguez-Pascual
- Dpt. of Clinical Biochemistry, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain
| | - Amalia Rubio
- Dpt. of Clinical Biochemistry, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain
| |
Collapse
|
12
|
Navas-Cuéllar JA, Álamo-Martínez JM, Bernal-Bellido C, Martín-Pérez B, Marín-Gómez LM, Suárez-Artacho G, Serrano-Díez-Canedo J, Gómez-Bravo MÁ, Padillo-Ruiz J. Neuroendocrine carcinoma of the common bile duct. Rev Esp Enferm Dig 2014; 106:558-560. [PMID: 25544418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
|
13
|
Marente VC, Gomez LMM, Martinez JG, Bernal-Bellido C, Suárez-Artacho G, Alamo-Martínez JM, Barrera-Pulido L, Serrano-Díaz-Canedo J, Padillo-Ruiz FJ, Gómez-Bravo MA. Modigraf administration through jejunostomy in liver transplant recipient: case report. Transplant Proc 2013; 45:3670-1. [PMID: 24314992 DOI: 10.1016/j.transproceed.2013.09.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We report our experience with a 61-year-old patient with alcoholic and hepatitis C cirrhosis who underwent liver transplantation. On the 3rd postoperative day he presented a mediastinitis secondary to esophageal perforation produced by a Linton tube. An esophagectomy with jejunostomy was performed. Tacrolimus granules for oral suspension (Modigraf) were administered through the jejunostomy. This case report highlights the use of Modigraf and the absence of secondary effects. We observed biochemical parameters during the jejunostomy period. We discuss the administration strategy applied and whether tacrolimus granules for oral suspension by jejunostomy affect the bioavailability and its side effects.
Collapse
Affiliation(s)
- V Camacho Marente
- Hepatobiliopancreatic Surgery Unit, General and Digestive Surgery, Virgen del Rocío University Hospitals, Seville, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Gutiérrez-Moreno M, Bernal-Bellido C, Suárez-Artacho G, Álamo-MartÍnez J, Marín-Gómez L, Serrano-Díaz-Canedo J, Padillo-Ruiz F, Gómez-Bravo M. Spontaneous Clearance of HCV in HIV–Hepatitis C Virus Coinfected Liver Transplant Patients: Prospective Study. Transplant Proc 2012; 44:2100-2. [DOI: 10.1016/j.transproceed.2012.07.074] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
15
|
Casado-Maestre MD, Alamo-Martínez JM, Segura-Sampedro JJ, Durán-Izquierdo E, Marín-Gómez LM, Bernal-Bellido C, Suárez-Artacho G, Serrano-Díez-Canedo J, Gómez-Bravo MÁ, Padillo-Ruiz FJ. Ascaris lumbricoides as etiologic factor for pancreas inflammatory tumor. Rev Esp Enferm Dig 2012; 103:592-3. [PMID: 22149563 DOI: 10.4321/s1130-01082011001100008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- María Dolores Casado-Maestre
- Department of General Surgery and Digestive Diseases, Hospitales Universitarios Virgen del Rocío, Sevilla, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Marín-Gómez LM, Sobrino-Rodríguez S, Alamo-Martínez JM, Suárez-Artacho G, Bernal-Bellido C, Serrano-Díaz-Canedo J, Padillo-Ruiz J, Gómez-Bravo MA. Use of fully covered self-expandable stent in biliary complications after liver transplantation: a case series. Transplant Proc 2011; 42:2975-7. [PMID: 20970587 DOI: 10.1016/j.transproceed.2010.08.023] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
AIMS To present our case series of fully covered self-expandable metallic stents (FCSESs) placed to treat biliary stenosis after liver transplantation and leakage after failure of plastic stenting. MATERIALS AND METHODS We retrospectively reviewed the courses of patients who had undergone liver transplantation with a biliary complication that was treated by an FCSES installed by endoscopic retrograde cholangiopancreatography. We evaluated the following variables: gender, age, indication for transplantation, time between transplant and diagnosis of the complication, number of plastic stents placed before the FCSES, and procedure-related complications. RESULTS From April 2008 to March 2010, 11 patients who had undergone a duct-to-duct anastomosis suffered posttransplant biliary stenosis or leakage with failure of endoscopic treatment using a plastic biliary stent: Namely, eight cases of stenosis and three of biliary leaks. Three patients underwent a papillotomy to place the FCSES, with no significant morbidity. No severe complications were observed after the endoscopic treatments; two patients developed mild pancreatitis; two, hyperamylasemia; and one, mild biliary sepsis. We removed the FCSES after a mean of 280 (range=173-310) days. Five patients lost the FCSES spontaneously. One patient underwent a choledocojejunostomy and two are waiting biliary surgery. CONCLUSION We avoided cholangiojejunostomy in 6/9 cases (not including the two deaths). Papillotomy did not engender a greater morbidity. The spontaneous loss of the stent is a problem that need to be resolved.
Collapse
Affiliation(s)
- L M Marín-Gómez
- Liver Transplantation Unit, Digestive Surgery Department, Universitary Hospital Virgen del Rocio, Sevilla, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Marín-Gómez LM, Gómez-Bravo MA, Bernal-Bellido C, Alamo-Martínez JM, Suárez-Artacho G, Serrano-Díez-Canedo J. Variability of the extrahepatic arterial anatomy in 500 hepatic grafts. Transplant Proc 2011; 42:3159-61. [PMID: 20970635 DOI: 10.1016/j.transproceed.2010.05.078] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
PURPOSE To review the extrahepatic arterial anatomy in 500 consecutive liver grafts. MATERIALS AND METHODS From April 1990 to January 2005 we performed 500 liver transplantations. We received 108 deceased donor liver grafts (21.4%) from other centers. Donor arterial anatomy was recorded as described in the surgical notes of both the donor harvest and the recipient procedures. We used the modified Michels classification scheme proposed by Busuttil. We assessed incidences of mortality, retransplantation, postreperfusion syndrome, intraoperative arrest, hemorrhagic complications, and primary malfunction, comparing with chi-squared tests. RESULTS There were 376 type I (75.2%), 51 type II (10.2%), 32 type III (6.4%), 18 type IV (3.6%), 3 type V (0.6%), 2 type VI (0.4%) and 18 others (3.6%). No significant associations were found between arterial vascular anomalies of the graft and the studied variables. CONCLUSION In our experience, extrahepatic arterial anomalies of the donor graft did not influence the short-term outcomes of liver transplantation.
Collapse
Affiliation(s)
- L M Marín-Gómez
- Liver Transplantation Unit, Digestive Surgery Department, Virgen del Rocio University Hospital, Seville, Spain.
| | | | | | | | | | | |
Collapse
|
18
|
Marín-Gómez L, Gómez-Bravo M, Barrera-Pulido L, Bernal-Bellido C, Álamo-Martínez J, Suárez-Artacho G, Díez-Canedo J, Sousa-Martín J. Outcomes of Domino Liver Transplantation: A Single Institution's Experience. Transplant Proc 2010; 42:644-6. [DOI: 10.1016/j.transproceed.2010.02.012] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
19
|
Marín-Gómez LM, Cordero-Matía E, Gómez-Bravo MÁ, Bernal-Bellido C. [Everolimus-associated pneumonitis in adult liver transplant recipient]. Med Clin (Barc) 2009; 135:431-2. [PMID: 19819477 DOI: 10.1016/j.medcli.2009.07.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2009] [Accepted: 07/15/2009] [Indexed: 11/19/2022]
|
20
|
Barrera-Pulido L, Álamo-Martínez J, Marín-Gómez L, Suárez-Artacho G, Bernal-Bellido C, Domínguez-Usero D, Tallón-Aguilar L, Pareja-Ciuró F, Sousa-Martín J, García-González I, Gómez-Bravo M. Switching From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Liver Transplant Patients With Gastrointestinal Complications. Transplant Proc 2009; 41:2192-4. [DOI: 10.1016/j.transproceed.2009.06.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
21
|
Martínez-Vieira A, Valera-Sánchez Z, Sousa-Vaquero JM, Palacios-González C, García-Poley A, Bernal-Bellido C, Alamo-Martínez JM, Millán-López A, Blanco-Domínguez M, Galindo-Galindo A. Rotura ureteral iatrogénica de causa inusual. Cir Esp 2005; 78:109-11. [PMID: 16420807 DOI: 10.1016/s0009-739x(05)70900-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Rupture of the ureter is an infrequent event that can have serious consequences. The most frequent cause is surgical iatrogenic ureter disease. Other possible causes are urological procedures and urographic studies. In our patient, which, to our knowledge, is the first to be reported in the literature, the ureteral rupture was produced by a traumatic urinary catheterism, because the balloon was filled inside the ureter. The normal presentation is nephritic colic, although acute abdomen is also a possibility. The possibility of ureteral rupture in abdominopelvic surgery or in urological techniques should be evaluated when patients present these clinical symptoms. Treatment is surgical, although in some cases conservative measures can be used.
Collapse
|